ArticleMolecular therapy : the journal of the American Society of Gene Therapy2005

Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice.

Edgardo Rodriguez-Lebron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.